At its sixth edition in 2017, Osseo, the International Congress on Bone Conduction Hearing and Related Technologies, brings together surgeons, audiologists, industry specialists, researchers, and academics within the field of bone conduction.
Cochlear’s unique implant and sound processor technology, and the clinical studies that attest it, as well as new products are some of the topics that will be discussed in the four-day event that sees participation from all over the world. A special focus this year is on the clinical evidence supporting the benefits of Cochlear’s Baha® 5 System, the most complete osseointegrated hearing solution on the market. The clinical evidence will present the proven benefits of Cochlear’s Baha® Attract System, and Baha Connect® System, in terms of hearing performance, aesthetics, and reliability.
A platinum sponsor and one of the founders of the event, Cochlear participates at the Osseo congress as not only an industry leader, but also an industry creator. A special satellite symposium dedicated to its 40 years of innovation will provide a compelling insight into bone conduction hearing, and the latest technologies that have the opportunity to further improve hearing outcomes for people with conductive hearing loss, mixed hearing loss and SSD Osseo takes place 17 – 20 May 2017 in Nijmegen, the Netherlands.
Nijmegen is home to one of the first centres in the world to use the Brånemark’s method – the bone conduction hearing implant, in 1987, ten years after Mona Andersson became the world’s first recipient of a bone conduction implant. Anders Tjellström, the pioneer of the bone conduction implant surgery, and the surgeon who performed the first implant, is one of the honorary guests at Osseo 2017.
We will return with updates after the congress.